Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ESSA Pharma Inc EPIX

Healthcare Biotechnology
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EPIX)

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

PR Newswire 10 days ago

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

PR Newswire March 7, 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023

PR Newswire February 13, 2024

ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

PR Newswire February 6, 2024

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

PR Newswire January 25, 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023

PR Newswire December 12, 2023

ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference

PR Newswire November 21, 2023

ESSA Pharma to Present at the Jefferies London Healthcare Conference

PR Newswire November 8, 2023

ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement

PR Newswire November 6, 2023
View More News ››

Opinion & Analysis (NDAQ:EPIX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EPIX)

EPIX ..... I have to laugh at myself ; )

Funny how my emotions come back to haunt me ...... I made a $1 per share profit but I left about $2 on the table.....ya just never know...
Iseneschal - October 26, 2022

EPIX ..... Yeeeehaaaaa !

Now Over $3...... Cha f'king Ching !!!!
Iseneschal - October 26, 2022

EPIX ....On watch list

Relative volume and NR.....$2.07
Iseneschal - October 26, 2022

ESSA has begun recruiting for its phase 1/2 combo trial

ESSA has filed an update on clinicaltrials.gov announcing that it has begun recruiting patients for its phase 1/2 combination trial (EPI...
allison5120 - October 24, 2021

Evercore SII 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore SII 3rd Annual HealthCONx Conference       HOUSTON and...
SilentRiver - November 25, 2020

Upcoming Investor Conferences

ESSA Pharma to Participate in Upcoming Investor Conferences       HOUSTON and VANCOUVER, BC,&...
SilentRiver - November 11, 2020
View more Bullboard ››

Steppe Gold Ltd

Steppe Gold Ltd

Steppe Gold Ltd. is engaged in the business of precious metals and minerals exploration sector. Its project includes Altan ...
View More »